登录 | 注册    关注公众号  
微信公众号
搜索
 >  Cell Grade Beads>CD19 >MBS-C034

ActiveMax® Human CD19 μBeads (non magnetic), premium grade (for cells)

热销产品推荐:The Magnetic Stand (Cat.No. MB-01 & Cat.No. MB-02) can be used in conjunction with Beads.

ProductSizeAmount
ActiveMax® Human CD19 μBeads (non magnetic), premium grade (for cells)2.5 mg2.5 × 10⁷ beads
10 mg (2.5 mg × 4)1.0 × 10⁸ beads

背景(Background)

ActiveMax® Human CD19 μBeads (non magnetic), premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

表达区间及表达系统(Source)

ActiveMax® Human CD19 μBeads (non magnetic), premium grade (for cells) are polystyrene microspheres, non-magnetic beads of 5.5 µm with streptavidin on its surface and coupled with biotinylated Human CD19 Protein, expressed from human 293 cells (HEK293) and contains AA Pro 20 - Lys 291 (Accession # P15391-1).

应用说明(Application)

ActiveMax® Human CD19 μBeads (non magnetic), premium grade (for cells) are designed to stimulate in vitro CD19-specific CAR-T cells or UCAR-T cells, similar to the tumor cell lines that express human CD19 antigen. It can be used as follows:
Evaluating the characteristics of CAR-T cells or UCAR-T cells.
In vitro expansion of CD19-specific CAR-T cells or UCAR-T cells.

存储(Storage)

This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.

Please avoid repeated freeze-thaw cycles after reconstitution. Immediate use after reconstitution is highly recommended.

制剂(Formulation)

Please contact us for detailed information.

Contact us for customized product form or formulation.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CD19靶点信息
英文全称:B-lymphocyte antigen CD19
中文全称:B淋巴细胞抗原CD19
种类:Homo sapiens
上市药物数量:12详情
临床药物数量:310详情
最高研发阶段:申请上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定